Nothing Special   »   [go: up one dir, main page]

HU0900195D0 - Diagnosis and treatment of gluten-induced autoimmune diseases - Google Patents

Diagnosis and treatment of gluten-induced autoimmune diseases

Info

Publication number
HU0900195D0
HU0900195D0 HU0900195A HUP0900195A HU0900195D0 HU 0900195 D0 HU0900195 D0 HU 0900195D0 HU 0900195 A HU0900195 A HU 0900195A HU P0900195 A HUP0900195 A HU P0900195A HU 0900195 D0 HU0900195 D0 HU 0900195D0
Authority
HU
Hungary
Prior art keywords
gluten
diagnosis
treatment
autoimmune diseases
induced autoimmune
Prior art date
Application number
HU0900195A
Other languages
English (en)
Original Assignee
Debreceni Egyetem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debreceni Egyetem filed Critical Debreceni Egyetem
Priority to HU0900195A priority Critical patent/HU0900195D0/hu
Publication of HU0900195D0 publication Critical patent/HU0900195D0/hu
Priority to CA2757598A priority patent/CA2757598A1/en
Priority to US13/262,211 priority patent/US20130045493A1/en
Priority to EP10721197.1A priority patent/EP2414842B1/en
Priority to PCT/HU2010/000036 priority patent/WO2010116196A2/en
Priority to AU2010233514A priority patent/AU2010233514B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91045Acyltransferases (2.3)
    • G01N2333/91074Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G01N2333/91085Transglutaminases; Factor XIIIq (2.3.2.13)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0900195A 2009-04-01 2009-04-01 Diagnosis and treatment of gluten-induced autoimmune diseases HU0900195D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
HU0900195A HU0900195D0 (en) 2009-04-01 2009-04-01 Diagnosis and treatment of gluten-induced autoimmune diseases
CA2757598A CA2757598A1 (en) 2009-04-01 2010-04-01 Diagnosis and treatment of gluten-induced autoimmune diseases
US13/262,211 US20130045493A1 (en) 2009-04-01 2010-04-01 Diagnosis and treatment of gluten-induced autoimmune diseases
EP10721197.1A EP2414842B1 (en) 2009-04-01 2010-04-01 Diagnosis and treatment of gluten-induced autoimmune diseases
PCT/HU2010/000036 WO2010116196A2 (en) 2009-04-01 2010-04-01 Diagnosisof and treatment gluten-induced autoimmune diseases
AU2010233514A AU2010233514B2 (en) 2009-04-01 2010-04-01 Diagnosis of and treatment gluten-induced autoimmune diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0900195A HU0900195D0 (en) 2009-04-01 2009-04-01 Diagnosis and treatment of gluten-induced autoimmune diseases

Publications (1)

Publication Number Publication Date
HU0900195D0 true HU0900195D0 (en) 2009-06-29

Family

ID=47712904

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0900195A HU0900195D0 (en) 2009-04-01 2009-04-01 Diagnosis and treatment of gluten-induced autoimmune diseases

Country Status (6)

Country Link
US (1) US20130045493A1 (hu)
EP (1) EP2414842B1 (hu)
AU (1) AU2010233514B2 (hu)
CA (1) CA2757598A1 (hu)
HU (1) HU0900195D0 (hu)
WO (1) WO2010116196A2 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2462439B1 (en) * 2009-11-11 2016-08-10 Zedira GmbH Stabilized open form transglutaminase as a diagnostic indicator for autoimmune diseases
DE102011118015A1 (de) * 2011-09-26 2013-03-28 Charité - Universitätsmedizin Berlin IgY-Zusammensetzung für die Verwendung in der Zöliakie
GB201209096D0 (en) 2012-05-24 2012-07-04 Medical Res Council Technology Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6720165B2 (en) * 2001-06-14 2004-04-13 Zyomix, Inc. Methods for making antibody fragments and compositions resulting therefrom
DK1563300T3 (da) * 2002-11-20 2012-07-23 Univ Leland Stanford Junior Diagnostisk fremgangsmåde til cøliaki
WO2006100678A2 (en) * 2005-03-23 2006-09-28 Yuval Haim Dagan Pyrotechnic device and pyrotechnic display comprising the same
ATE511651T1 (de) * 2007-04-06 2011-06-15 Zedira Gmbh Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen

Also Published As

Publication number Publication date
US20130045493A1 (en) 2013-02-21
CA2757598A1 (en) 2010-10-14
AU2010233514B2 (en) 2016-05-26
EP2414842A2 (en) 2012-02-08
WO2010116196A2 (en) 2010-10-14
EP2414842B1 (en) 2018-05-16
WO2010116196A3 (en) 2010-12-02
AU2010233514A1 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
IL267014A (en) Preparations and methods for the treatment of autoimmune diseases and other diseases
HK1200745A1 (en) Medical connectors and methods of use
ZA201100974B (en) Treatment of autoimmune and inflammatory disease
HK1171168A1 (zh) 利用拉喹莫德治療克羅恩病
EP2498796A4 (en) TREATMENT OF HEART DISEASES
EP2605827A4 (en) NON-INVASIVE TREATMENT OF BRONCHOCONSTRICTION
EP2387611A4 (en) DIAGNOSIS AND TREATMENT OF AUTISTICAL DISEASES
ZA201301601B (en) Treatment of diseases
HK1169455A1 (zh) 阿爾茨海默病的診斷和治療
EP2613786A4 (en) TREATMENT OF DISEASES
GB0908193D0 (en) Treatment of disease state
PT2614832T (pt) Diagnóstico de pré-eclâmpsia
HUE064745T2 (hu) Módszerek és készítmények a rák diagnosztizálására és kezelésére
GB0922085D0 (en) Cancer diagnosis and treatment
PL3241910T3 (pl) Sposoby diagnozowania i leczenia choroby autoimmunologicznej wtórnej względem stwardnienia rozsianego
GB0918392D0 (en) Diagnostic and therapeutic methods
EP2403624A4 (en) DIAGNOSTIC DEVICES AND METHODS OF USE
EP2603609A4 (en) TREATMENT AND DIAGNOSIS OF EPIGENETIC DISORDERS AND DISORDERS
EP2454372A4 (en) TREATMENT AND DIAGNOSIS OF IMMUNE DISORDERS
EP2470268A4 (en) PURING-ORIENTED DIAGNOSIS AND THERAPY OF WOUNDS
PL2435026T3 (pl) Leczenie zrostu tkanek
EP2420515A4 (en) DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-TMPRSS11E ANTIBODY
EP2488198A4 (en) TREATMENT AND DIAGNOSIS OF INFLAMMATORY DISORDERS
IL217133A0 (en) Diagnosis and treatment of autoimmune demyelinating diseases
EP2361317A4 (en) USE OF EIF3M FOR THE DIAGNOSIS AND TREATMENT OF CANCER